Search results for: factor
#39374066 
2024/10/07
To Up
A Scoping Review of Factors Influencing Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease.
To provide a scoping review of studies on factors affecting smoking cessation in patients with chronic obstructive pulmonary disease (COPD), so as to provide a basis for healthcare professionals to intervene early in the process of cessation of smoking in patients with COPD, and to formulate personalized interventions for smoking cessation. Arksey and O'Malley's scoping review methodology as a framework, searched databases including CNKI, Wanfang Data, VIP, China Biomedical Database, PubMed, Web of Science, Embase, ProQuest, CINAHL, and Cochrane Library to collect literature on factors influencing smoking cessation among COPD patients. The literature was screened, data extracted, and summarized accordingly. A total of 28 papers were included. The socio-demographic related factors affecting smoking cessation in patients with COPD were age, educational level, residence, marital status, occupational status, economic status, race, and sex; tobacco related factors included smoking index, smoking duration (years), cumulative smoking (packs/year), smoking intensity (packs/day), and tobacco addiction; disease related factors included mMRC score, GOLD level, severity of airflow restrictions, symptom, activity limitation due to lung problems, history of deterioration in outpatient care, receipt of COPD medication, receipt of lung CT, receipt of pulmonary function tests, receipt of surgery, and comorbid comorbidities; psychologically related factors included mental health status, quit smoking health beliefs, smoking cessation self-efficacy, motivation to quit smoking, stress, and adverse emotions; environmental/Interpersonal network related factors-included environmental impacts, social support, family support, tobacco control policies, and satisfaction with cessation care; and behavior related factors included alcohol consumption, coffee consumption, eating, physical activity, and have a hobby. Healthcare professionals should avoid critical education of COPD patients in the process of smoking cessation management, pay attention to the adverse effects of medication side effects on patients, emphasize the improvement of patients' health beliefs and self-efficacy in smoking cessation, and help patients to establish a correct cognition of smoking cessation.Tong Huimin, Tian Zheng, He Jingchun, Liu Dajun, Zhang Zhijun, Li Yuan, Zhang Nan, Wang Lan
2810 related Products with: A Scoping Review of Factors Influencing Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease.
50 UG1 mg1-99 mg/ml/ea price x 296 tests
Related Pathways
#39374051 2024/10/07
To Up
Proposed categories for reporting of service organization in rehabilitation in clinical trials: a discussion paper.
The lack of standardized reporting for crucial organizational factors in rehabilitation poses a significant barrier to understanding their impact on patient outcomes in clinical trials and meta-analyses.Cecilie Røe, Christoph Gutenbrunner, Andrea Bökel, Marit Kirkevold, Boya Nugraha, Nada Andelic, Juan Lu, Erik Bautz-Holter, Paul B Perrin, Audny Anke, Reidun Jahnsen, Grethe Månum, Emilie Howe, Line Kildal Bragstad, Helene L Soberg
1141 related Products with: Proposed categories for reporting of service organization in rehabilitation in clinical trials: a discussion paper.
Related Pathways
#39374042 2024/10/08
To Up
Evaluation of akathisia in patients receiving selective serotonin reuptake inhibitors/serotonin and noradrenaline reuptake inhibitors.
Akathisia is an underestimated but disturbing extrapyramidal side effect of antidepressants, which could reduce treatment compliance in mood disorders. This study aimed to investigate the frequency and risk factors in patients treated with selective serotonin reuptake inhibitors/serotonin and noradrenaline reuptake inhibitors (SSRI/SNRI). In addition, we assessed the impact of akathisia on the quality of life (QoL). Patients were aged between 18 and 75 years, receiving an SSRI/SNRI for 4-8 weeks, and were diagnosed with anxiety, depression, or obsessive-compulsive disorder. The Barnes Akathisia Rating Scale was used to assess the severity of the akathisia. QoL was evaluated using the Short Form 36 (SF-36) questionnaire. Akathisia was observed in 25% (50/198) of patients. Smokers and younger patients were more frequent among patients with akathisia. Physical functioning, physical role, vitality, and mental health domains of the SF-36 were reduced in the presence of akathisia. In conclusion, our results suggest that akathisia is not a rare side effect of SSRI/SNRI in patients with mood disorders, especially in smokers and younger patients. In addition, akathisia may reduce treatment compliance owing to a reduction in QoL. Further investigations are needed to confirm the risk factors, frequency, and consequences of treatment compliance for SSRI/SNRI-induced akathisia in patients with mood disorders.Ismail Akgoz, Huseyin Kara, Ozgen Ozcelik, Levent Donmez, Mehmet Eryilmaz, Gul Ozbey
1095 related Products with: Evaluation of akathisia in patients receiving selective serotonin reuptake inhibitors/serotonin and noradrenaline reuptake inhibitors.
100 μg14 inhibitors3 inhibitors100 μg7 inhibitors5mg6 inhibitors8 inhibitors10mg400Tests5 inhibitors10mg
Related Pathways
#39374041 2024/10/07
To Up
Proximal Tubule Secretory Clearance, Injury, and Kidney Viability in Cirrhosis.
Cirrhosis affects all structures of the kidney, in particular the tubules which are responsible for secretion of protein-bound metabolites and electrolyte/water homeostasis. Yet, prevailing assessments of kidney function focus solely on glomerular filtration rate (GFR) which may incompletely reflect these processes. We sought to characterize markers of tubular function, injury, and viability in patients with and without cirrhosis.Michael L Granda, Eric Luitweiler, David K Prince, Andrew S Allegretti, Cary Paine, Raimund Pichler, Lena Sibulesky, Scott W Biggins, Bryan Kestenbaum
1369 related Products with: Proximal Tubule Secretory Clearance, Injury, and Kidney Viability in Cirrhosis.
96T
Related Pathways
#39374018 2024/10/01
To Up
Post-COVID-19 Condition Fatigue Outcomes Among Danish Residents.
Fatigue remains one of the most common and debilitating symptoms of post-COVID-19 condition; however, existing studies are limited to select populations and often lack noninfected controls. It also remains unclear to what extent severity of infection and psychiatric conditions, which are often linked to chronic fatigue, modify the risk of post-COVID-19 condition fatigue symptoms.Elisabeth O'Regan, Lampros Spiliopoulos, Ingrid Bech Svalgaard, Nete Munk Nielsen, Anna Irene Vedel Sørensen, Peter Bager, Poul Videbech, Steen Ethelberg, Anders Koch, Anders Hviid
2320 related Products with: Post-COVID-19 Condition Fatigue Outcomes Among Danish Residents.
25 G 25 G 25 G100 MG 500 ml 25 G1 mg 25 G1 g100 MG 25 G
Related Pathways
#39374015 2024/10/01
To Up
Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
In metastatic hormone-sensitive prostate cancer (mHSPC), new first-line combination therapies have enhanced overall survival (OS), but clinical outcomes for individual patients vary greatly and are difficult to predict. Peripheral blood circulating tumor cell (CTC) count is the most extensively validated prognostic liquid biomarker in metastatic castration-resistant prostate cancer (mCRPC), and recent studies have suggested that it may also be informative in mHSPC.Amir Goldkorn, Catherine Tangen, Melissa Plets, Daniel Bsteh, Tong Xu, Jacek K Pinski, Sue Ingles, Timothy Junius Triche, Gary R MacVicar, Daniel A Vaena, Anthony W Crispino, David James McConkey, Primo N Lara, Maha H A Hussain, David I Quinn, Tanya B Dorff, Seth Paul Lerner, Ian Thompson, Neeraj Agarwal
1730 related Products with: Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Related Pathways
#39374014 2024/10/01
To Up
Area-Level Social Deprivation and Cytomegalovirus Seropositivity at the Time of Solid Organ Transplant.
Cytomegalovirus (CMV) is associated with significant morbidity and mortality in solid organ transplant (SOT) recipients. The risk factors for CMV seropositivity in SOT recipients, including area-level social deprivation in the US, have not been fully characterized.Maheen Z Abidi, Rocio Lopez, Susana Arrigain, Adriana Weinberg, Bruce Kaplan, Mara McAdams-DeMarco, Jesse D Schold, Kristine M Erlandson